País: Nova Zelândia
Língua: inglês
Origem: Medsafe (Medicines Safety Authority)
Phenytoin sodium 50 mg/mL
Pfizer New Zealand Limited
Phenytoin sodium 50 mg/mL
50 mg/mL
Solution for injection
Active: Phenytoin sodium 50 mg/mL Excipient: Ethanol Hydrochloric acid Propylene glycol Sodium hydroxide Water for injection
Ampoule, glass, 5x2mL, 10 mL
Prescription
Prescription
Katwijk Chemie BV
Latest Regulatory Activity
Package - Contents - Shelf Life: Ampoule, glass, 5x2mL - 10 mL - 18 months from date of manufacture stored at or below 25°C protect from light - Ampoule, glass, 5x5mL - 25 mL - 18 months from date of manufacture stored at or below 25°C protect from light
1993-02-26
Version: pfdpheni10123 Supersedes: pfdpheni11022 Page 1 of 24 NEW ZEALAND DATA SHEET 1. PRODUCT NAME DBL ™ Phenytoin Injection 50 mg/mL Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION DBL Phenytoin Injection is a ready mixed solution of phenytoin sodium. Each mL of solution contains phenytoin sodium 50 mg (100 mg/2 mL, 250 mg/5 mL) propylene glycol 0.4 mL and ethanol 0.1 mL in Water for Injection adjusted to pH 12 with either sodium hydroxide or hydrochloric acid. Excipient(s) with known effect • Alcohol For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection DBL Phenytoin Injection is a clear, colourless solution, free from visible particulates. Phenytoin sodium is the sodium salt of phenytoin. It is soluble in water and alcohol. It is a white, odourless, slightly hygroscopic crystalline powder. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the control of status epilepticus, tonic-clonic (grand mal), psychomotor seizures and the prevention of seizures occurring during or following neurosurgery. Phenytoin will prevent or effectively decrease the incidence and severity of convulsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. Besides its effectiveness in controlling seizures, phenytoin frequently improves the mental condition and outlook of epileptic patients. It has also been used in the treatment of certain cardiac arrhythmias, particularly in those patients who do not respond to conventional antiarrhythmic agents or to cardioversion. Phenytoin serum level determinations may be necessary for optimal dosage adjustments (see section 4.2). 4.2 DOSE AND METHOD OF ADMINISTRATION DOSE _STATUS EPILEPTICUS:_ For the control of status epilepticus in adults, a loading dose of 10 to 15 mg/kg should be administered slowly intravenously, at a rate not exceeding 50 mg/min. This Version: pfdpheni10123 Supersedes: pfdpheni11022 Page 2 of 24 will require approximately 20 minutes in a 70 Leia o documento completo